Cross-species transplant in rhesus macaques is step toward diabetes cure ... ( St. Louis Oct. 18 2007 With an eye ...)

Cross-species transplant in rhesus macaques is step toward diabetes cure for humans

Date:10/18/2007

St. Louis, Oct. 18, 2007 With an eye on curing diabetes, scientists at Washington University School of Medicine in St. Louis have successfully transplanted embryonic pig pancreatic cells destined to produce insulin into diabetic macaque monkeys all without the need for risky immune suppression drugs that prevent rejection.

The transplanted cells, known as primordia, are in the earliest stages of developing into pancreatic tissues. Within several weeks of the transplants, the cells became engrafted, or established, within the three rhesus macaque monkeys that received them. The cells also released pig insulin in response to rising blood glucose levels, as would be expected in healthy animals and humans.

"The approach reduced the animals' need for insulin injections and has promise for curing diabetes in humans," says senior investigator Marc Hammerman, M.D., the Chromalloy Professor of Renal Diseases in Medicine. "The transplants worked without a need for immune suppression and that is a major obstacle we have overcome."

The researchers' results appear online and will be published in the journal Xenotransplantation in November.

Although the transplants fell short of producing sufficient insulin to cure the macaques' diabetes, Hammerman predicts that with additional research, including the transplantation of additional embryonic pig cells into the animals, he will be able to reduce their need for insulin injections entirely.

The new research follows on the heels of reports by Hammerman and his colleagues demonstrating that transplanted pig pancreatic primordia can cure both type 1 and type 2 diabetes in rats, without using immune suppression drugs. Other scientists have tried different types of pancreatic cell transplants in animals and humans as a stepping stone to curing diabetes, but they all require anti-rejection drugs. These drugs must be taken daily to stave off rejection and have adverse effects of their own that limit the su
'/>"/>

Contact: Caroline Arbanas
arbanasc@wustl.edu
314-286-0109
Washington University in St. Louis
Source:Eurekalert

1

GOOD

Page: 1 2 3
Related medicine news :

1. Infant receives first bloodless liver transplant
2. Liver donors can thrive after transplant
3. ATG useful in transplant patients as substitute for steroids
4. Transplant helps diabetes
5. Larynx transplant restores patients voice after 20 years
6. Baby Lennox Gets Liver Transplant
7. Chinese Girl To Undergo Face Transplant Surgery
8. Stem cell transplantation of eye
9. Woman gets cancer from transplanted kidney
10. Parasite infections linked to organ transplants
11. Vitamins enhances recuperation of organ transplant patients

Post Your Comments:

(Date:5/24/2013)... A recent study by research group Harris Interactive found ... suit season. Almost 138 million people are fearful of pulling ... weight issues and a quarter admit they feel pressured to ... that those anxious about their size consider the over the ... overall effort to improve diet and exercise habits ahead of ...

(Date:5/24/2013)... Compromise is often cited as crucial for ... to sleep and comfort. However, many couples find themselves facing ... some, this can cause added stress, lost sleep, and some ... eight common issues in their latest article on the subject. ... Firm: What to do When You Disagree on the Best ...

(Date:5/24/2013)... 24, 2013 DePuy ASR lawsuit ... continue to move forward in courts throughout the country, ... in California’s San Francisco Superior Court on April 25th, ... of her DePuy hip lawsuit is voluntarily seeking dismissal ... et al., No. CGC11508806; Calif. Super. Ct., San Francisco). ...

(Date:5/24/2013)... 2013 KC and Monica Craichy, Founders of ... FreeRide836. Their oldest sons, Kyle and Austin Craichy, will be ... and several professional kiteboarders. , KC Craichy said he is ... miraculously come together such that virtually everyone who planned to ... 20 kite boarders will meet at Matheson Hammock Park and ...

(Date:5/24/2013)... 24, 2013 CHI-California Healthcare Institute ... the California congressional delegation, joined by over 40 ... user fees paid to the U.S. Food and ... future across-the-board cuts will not include user fees ... Agriculture, Rural Development and FDA Appropriations Bill. CHI ...

Breaking Medicine News(10 mins):Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2 Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3 Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2 Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2 Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3 Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4 Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2 Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3

[0] PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful [0] What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples [0] DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case [0] FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa [0] California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014

... , , , ... Aug. 18 Cardinal Health today reported fiscal 2009 diluted earnings per ... basis(1), which was in line with the company,s expectations and includes a ... manufacturing business as discontinued operations. , , The ...

... , ... HemCon Medical Technologies, Inc. today announced that ... two products added to the Hemostasis Products category with Premier Purchasing ... is effective August 1, 2009 through Oct 1, 2011. The agreement ...

... ... , ... 18, 2009 -- Inc. magazine recently included Enovate in its annual Inc. 5000 ... revenue growth from the last four years, is a comprehensive look at one of the ...

... ... Specialists, Avisena, Announces Increased Earnings for the Second Quarter, Including Positive Operating Profit for ... ... company servicing the health care industry that offers a proprietary, Internet-based technology platform, announced ...

... , , , ... Plans (CDHPs) in the U.S. have surpassed HMO plans in covered ... from its 2009 UBA Health Pl a ... with 17,655 plans from 12,316 employers reporting. , , ...

... 17 Attendance on Demand employee time and attendance service ... 5 Tools to Control Labor Costs" Wednesday, August 26 -- ... ebinar/index.html , , The ... cost of labor, the most significant expense faced by the ...

Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook Hemostatic HemCon Dressings Selected by the Premier Healthcare Alliance for Hemostasis Products Contract Inc. Magazine Names Enovate as One of the Fastest-Growing Private Companies in the US.Avisena Announces Major Increases in Profit for Second Quarter 2009 Consumer Driven Health Plans Surpass HMOs in Popularity With Employees Attendance on Demand, Inc. Hosts Free Webinar 'Top 5 Tools to Control Labor Costs' for Long-Term Healthcare Professionals 2:30pm EDT August 26, 2009

(Date:5/23/2013)... PAUL, Minn. , May 23, 2013 MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...

(Date:5/23/2013)... , May 23, 2013 The need to ... treatment continuum was highlighted prominently at the 108 ... Association (AUA), in San Diego. According to SonaCare ... focused ultrasound (HIFU) technology, the need for image-guided ... for urologists to consider minimally invasive ablative treatments, ...

(Date:5/23/2013)... 23, 2013 Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...

Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6 Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2 Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3

[0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 [0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting [0] Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients

... 2012 /PRNewswire-iReach/ -- Precision Antibody, ... announced today that they have expanded their ... RED96™ system, a multi-functional, label-free, real-time binding ... Antibody has been providing antibody characterization services ...

... 2012 In a historic open letter to ... the Coalition for Mercury-Free Drugs (CoMeD) , and the United ... in human drugs, especially vaccines. Currently, the mercury-based preservative Thimerosal, ... the United States and much of the world, despite the ...

Cached Medicine Technology:Precision Antibody Expands Antibody Characterization Services 2 Global Call for Mercury-free Vaccines Issued 2

Precision Antibody Expands Antibody Characterization Services Global Call for Mercury-free Vaccines Issued

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Arylsulfatase A, Urine Arthropod Identification Arsenic, Tissue Arsenic, Nails